Specifically, intratumoral bacteria inhibit cancer cell immune escape mechanisms by presenting bacterial peptides to MHC molecules, promoting T cell infiltration and enhancing their cytotoxic capacity against tumor cells, ultimately improving ICI efficacy [61]. Here, HLA-C is linked to cancer.